Abstract
Some advanced stage peripheral arterial disease (PAD) patients will not eligible for revascularization strategies. From the last two decades stem cell therapy (SCT) has been explored as an alternative therapy for no option advanced stage PAD patients. Therapeutic motif of this novel therapy is to promote the collateral vessel formation that will improve the blood flow to ischemic leg that in turn can prevent major amputations. This mini review provides the brief outline of the use of autologous and allogeneic SCT for the treatment of advanced stage PAD
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
